Description

Cerebrolysin 60MG

We provide Cerebrolysin as a 60MG research preparation with a stated 99.1% purity. Furthermore, this material represents a complex preparation of low-molecular-weight peptides and amino acids derived from porcine brain proteins rather than a single defined peptide sequence. Consequently, researchers study it as a multi-component neuropeptide preparation across neurotrophic signaling, neuronal protection, synaptic plasticity, neurogenesis, and cellular stress pathways.

Key Attributes

• Brand: AvigenLab
• Product Name: Cerebrolysin
• Quantity: 60MG
• Stated Purity: 99.1%
• Molecular Type: Peptide-Based Neurotrophic Preparation
• Source: Porcine Brain-Derived Proteins
• Composition: Low-Molecular-Weight Peptides and Amino Acids
• Product Format: Vial
• Classification: Research Use Only
• Human Use: Not For Human Use

Cerebrolysin Product Overview

We provide Cerebrolysin for research involving neurotrophic signaling, neuronal survival, neuroplasticity, neurogenesis, and neurological cellular mechanisms. Moreover, analytical research has characterized the preparation as peptide-rich material produced through hydrolysis and purification of porcine brain proteins.

Additionally, published research describes biological activity resembling aspects of endogenous neurotrophic-factor signaling. Therefore, researchers have investigated its relationship with pathways involving neuronal survival, synaptic plasticity, neurogenesis, inflammation, and oxidative stress.

You can explore additional research materials through our Online Store.

Cerebrolysin Product Identification

We identify Cerebrolysin as a 60MG research preparation with a stated 99.1% purity. Furthermore, unlike a conventional synthetic peptide with one defined amino-acid sequence, this preparation contains a mixture of low-molecular-weight peptides and free amino acids. Consequently, researchers should reference the preparation by its overall composition rather than assigning it a single peptide sequence.

Product Category

We classify Cerebrolysin within our neuropeptide and neurological research collection. Accordingly, its scientific profile centers on complex peptide-mediated interactions with neuronal and neurotrophic systems.

Moreover, analytical studies have identified hundreds of peptide components within examined samples, demonstrating the molecular complexity of the preparation. One mass-spectrometry investigation identified 638 unique peptides, while subsequent peptide-profiling research identified thousands of peptide sequences corresponding to proteins within the porcine neuronal proteome.

Scientific Characteristics

Cerebrolysin contains low-molecular-weight peptides and amino acids generated from porcine brain proteins. In particular, research has investigated whether these peptide components can produce biological effects resembling endogenous neurotrophic factors such as nerve growth factor and brain-derived neurotrophic factor.

Furthermore, researchers have examined potential interactions with pathways associated with neuronal survival, neurogenesis, synaptic plasticity, oxidative stress, and inflammatory signaling. Nevertheless, the precise molecular mechanism remains complex because the preparation contains numerous peptide components rather than one isolated active molecule.

Research Applications

We position Cerebrolysin for research involving neurotrophic signaling, neuronal protection, synaptic plasticity, neurogenesis, neuroinflammation, oxidative stress, and neurological cellular biology.

Additionally, experimental research has examined BDNF-related signaling and neuroprotective responses. For example, an in-vitro study reported increased BDNF expression following exposure to the preparation, while other studies have investigated effects involving neurotrophic pathways and neuronal survival.

Likewise, researchers have examined its relationship with neuroplasticity and neurogenesis. Moreover, experimental literature has investigated pathways involving PI3K/Akt, Sonic Hedgehog signaling, synaptic proteins, and neural progenitor-cell responses.

Product Configuration

We provide the material in a 60MG vial carrying a stated 99.1% purity designation. Accordingly, the quantity, purity, vial format, source description, and research classification establish clear reference points for laboratory inventory and catalog organization.

Furthermore, because this material represents a complex peptide preparation rather than a single synthetic peptide, we document its composition at the preparation level. Consequently, researchers can distinguish it from defined-sequence research peptides within our collection.

Product Features

The primary features include a 60MG quantity, 99.1% stated purity, peptide-based composition, and porcine brain-derived source. Additionally, the product label clearly communicates Not For Human Use | Research Use Only.

Moreover, the preparation’s research profile encompasses multiple biological pathways. Studies have investigated neurotrophic-factor-like activity, neuroplasticity, neurogenesis, oxidative-stress responses, inflammatory signaling, and neuronal survival. As a result, the material provides a broad experimental platform for neurological research rather than targeting one isolated molecular pathway.

Product Specifications

Intended Research Context

We identify the material as Research Use Only and Not For Human Use. Accordingly, our documentation focuses on laboratory investigation rather than therapeutic or consumer applications.

In particular, researchers can examine this preparation within experimental systems involving neurotrophic signaling, neuronal survival, synaptic plasticity, neurogenesis, inflammation, and oxidative stress. Furthermore, published research has investigated the preparation in cellular and animal models as well as clinical research settings.

Nevertheless, research findings vary according to preparation, experimental model, study design, and measured endpoint. Therefore, individual experimental observations should remain within their appropriate scientific context rather than being presented as established outcomes for this specific AvigenLab product.

Packaging Information

We present the product in a clearly labeled 60MG vial featuring our AvigenLab product presentation. The packaging identifies the material, displays the 60MG quantity, and communicates the stated 99.1% Purity designation.

Additionally, the label communicates Not For Human Use | Research Use Only. Therefore, the packaging provides straightforward product identification while supporting consistent laboratory inventory and catalog organization.

Regulatory Information

We classify the product as Research Use Only and maintain the Not For Human Use designation throughout our product documentation. Accordingly, research literature concerning the broader Cerebrolysin preparation does not constitute regulatory approval for this specific AvigenLab presentation.

Moreover, the preparation has been used as a neurological medicine in some countries, while evidence regarding specific clinical applications varies by indication and study. Therefore, our product documentation remains focused on research classification, molecular characteristics, and scientific reference information rather than therapeutic claims.

Storage and Handling

We recommend following the storage and handling conditions specified in the applicable AvigenLab product documentation. Because stability can depend on formulation, packaging, environmental exposure, and other product-specific variables, we avoid assigning unsupported storage parameters.

Furthermore, researchers should maintain appropriate laboratory handling practices and follow the product-specific documentation associated with the material. Consequently, this approach supports consistent laboratory management without introducing assumptions about conditions that may vary between formulations.

Market Availability

Our Cerebrolysin presentation provides a defined 60MG research configuration within our product collection. The product name, quantity, stated purity, peptide-based composition, source classification, vial format, and Research Use Only designation create clear reference points for laboratory inventory.

Moreover, the preparation’s established research history across neurotrophic signaling, neuronal protection, neuroplasticity, and neurological biology makes it a recognizable research material. Likewise, continuing analytical research into its peptide composition provides additional insight into the complexity of the preparation.

Product Reference

Our Cerebrolysin 60MG is a peptide-based research preparation derived from porcine brain proteins and presented with a stated 99.1% purity designation. We document the material according to its complex peptide composition, product configuration, neurological research relevance, and Research Use Only classification.

Consequently, the product provides researchers with a defined preparation for investigating neurotrophic signaling, neuronal protection, neuroplasticity, neurogenesis, oxidative stress, and related cellular pathways. Furthermore, analytical studies continue to characterize the diverse peptide composition underlying its biological research profile.